2024 Q2 Form 10-Q Financial Statement

#000074925124000024 Filed on April 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.595B $1.473B
YoY Change 6.11% 4.55%
Cost Of Revenue $513.3M $459.4M
YoY Change 5.31% 5.58%
Gross Profit $1.082B $1.013B
YoY Change 6.5% 4.08%
Gross Profit Margin 67.82% 68.81%
Selling, General & Admin $712.1M $689.3M
YoY Change 4.69% 4.91%
% of Gross Profit 65.83% 68.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $27.59M $49.31M
YoY Change 16.37% 106.34%
% of Gross Profit 2.55% 4.87%
Operating Expenses $712.1M $738.6M
YoY Change 4.69% 12.41%
Operating Profit $318.8M $274.8M
YoY Change 12.6% -32.63%
Interest Expense -$19.99M -$19.22M
YoY Change -181.4% -170.17%
% of Operating Profit -6.27% -6.99%
Other Income/Expense, Net $504.0K $4.891M
YoY Change -90.96% -306.72%
Pretax Income $299.3M $259.6M
YoY Change 13.32% -31.92%
Income Tax $69.70M $49.01M
% Of Pretax Income 23.29% 18.88%
Net Earnings $229.5M $210.5M
YoY Change 15.91% -28.82%
Net Earnings / Revenue 14.39% 14.29%
Basic Earnings Per Share $2.95 $2.69
Diluted Earnings Per Share $2.93 $2.67
COMMON SHARES
Basic Shares Outstanding 77.63M shares 77.97M shares
Diluted Shares Outstanding 78.29M shares 78.96M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.236B $1.236B
YoY Change 5.37% 38.31%
Cash & Equivalents $1.236B $1.236B
Short-Term Investments
Other Short-Term Assets $438.8M $494.7M
YoY Change 4.15% 7.08%
Inventory
Prepaid Expenses
Receivables $1.404B $1.596B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.109B $3.326B
YoY Change 7.23% 14.57%
LONG-TERM ASSETS
Property, Plant & Equipment $258.5M $608.9M
YoY Change -0.06% 137.07%
Goodwill $2.934B $2.934B
YoY Change 0.08% 0.15%
Intangibles $455.0M $477.7M
YoY Change -16.94% -15.32%
Long-Term Investments
YoY Change
Other Assets $334.5M $362.5M
YoY Change 4.44% 17.09%
Total Long-Term Assets $4.322B $4.384B
YoY Change -3.02% -2.06%
TOTAL ASSETS
Total Short-Term Assets $3.109B $3.326B
Total Long-Term Assets $4.322B $4.384B
Total Assets $7.431B $7.710B
YoY Change 1.02% 4.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $742.7M $745.7M
YoY Change 2.61% 0.89%
Accrued Expenses $92.57M $98.56M
YoY Change -11.86% -1.12%
Deferred Revenue $2.627B $2.796B
YoY Change 5.09% 7.25%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $3.462B $3.640B
YoY Change 3.73% 5.39%
LONG-TERM LIABILITIES
Long-Term Debt $2.458B $2.457B
YoY Change 0.27% 0.18%
Other Long-Term Liabilities $392.8M $894.5M
YoY Change -7.78% 111.22%
Total Long-Term Liabilities $2.851B $3.351B
YoY Change -0.92% 16.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.462B $3.640B
Total Long-Term Liabilities $2.851B $3.351B
Total Liabilities $6.784B $6.992B
YoY Change 0.22% 1.24%
SHAREHOLDERS EQUITY
Retained Earnings $5.179B $4.950B
YoY Change 19.05% 19.2%
Common Stock $82.00K $82.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $646.7M $718.2M
YoY Change
Total Liabilities & Shareholders Equity $7.431B $7.710B
YoY Change 1.02% 4.48%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $229.5M $210.5M
YoY Change 15.91% -28.82%
Depreciation, Depletion And Amortization $27.59M $49.31M
YoY Change 16.37% 106.34%
Cash From Operating Activities $370.0M $188.8M
YoY Change -15.1% 14.67%
INVESTING ACTIVITIES
Capital Expenditures $29.37M $22.66M
YoY Change 14.84% 7.28%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$2.000M
YoY Change -100.0% -101.26%
Cash From Investing Activities -$29.37M -$24.66M
YoY Change 3.96% -117.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $274.4M
YoY Change 15144.44%
Cash From Financing Activities -333.5M -219.7M
YoY Change 161.73% 116.88%
NET CHANGE
Cash From Operating Activities 370.0M 188.8M
Cash From Investing Activities -29.37M -24.66M
Cash From Financing Activities -333.5M -219.7M
Net Change In Cash 7.049M -55.51M
YoY Change -97.48% -127.61%
FREE CASH FLOW
Cash From Operating Activities $370.0M $188.8M
Capital Expenditures $29.37M $22.66M
Free Cash Flow $340.6M $166.2M
YoY Change -16.97% 15.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2024Q1 us-gaap Depreciation
Depreciation
26317000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
23896000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472926000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1408869000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
459441000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
435139000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
689833000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
657090000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22990000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22735000 usd
CY2024Q1 it Business Combination Acquisitionand Integration Related Costs
BusinessCombinationAcquisitionandIntegrationRelatedCosts
460000 usd
CY2023Q1 it Business Combination Acquisitionand Integration Related Costs
BusinessCombinationAcquisitionandIntegrationRelatedCosts
1368000 usd
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2023Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
139316000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
1199041000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1000912000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
273885000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
407957000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
19219000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
27391000 usd
CY2024Q1 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
CY2023Q1 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
3077000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4891000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2366000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
259557000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
381277000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49012000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85494000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.72
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.67
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.68
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78339000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79452000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78964000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80282000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9707000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1832000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
3601000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
3834000 usd
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-51000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-34000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6055000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5700000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
204490000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
301483000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
680634000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6055000 usd
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
8072000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
225522000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
50500000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
718174000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
227798000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5700000 usd
CY2023Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7379000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
108850000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
45048000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
472858000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
49307000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46631000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
50500000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
45048000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-17823000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7866000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
139316000 usd
CY2024Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
527000 usd
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
8720000 usd
CY2024Q1 it Operating Lease Right Of Use Asset Reduction In Carrying Amount
OperatingLeaseRightOfUseAssetReductionInCarryingAmount
16028000 usd
CY2023Q1 it Operating Lease Right Of Use Asset Reduction In Carrying Amount
OperatingLeaseRightOfUseAssetReductionInCarryingAmount
17644000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1537000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1161000 usd
CY2024Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
4462000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1393000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18228000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-36177000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-26413000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-19635000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47509000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18370000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
24309000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
14799000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
173542000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
155153000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-263688000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-282315000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
188836000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164679000 usd
CY2024Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
22660000 usd
CY2023Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
21122000 usd
CY2024Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2024Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 usd
CY2023Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
158733000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24660000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
137611000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8047000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7358000 usd
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2604000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
274400000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
274400000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1800000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
225124000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
106850000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-219681000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-101292000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-55505000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
200998000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-27693000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-5485000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1319599000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
698599000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1236401000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
894112000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The preparation of the accompanying interim Condensed Consolidated Financial Statements requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Such estimates include the valuation of fees receivable, goodwill, intangible assets and other long-lived assets, as well as tax accruals and other liabilities. In addition, estimates are used in revenue recognition, income tax expense or benefit, performance-based compensation charges, depreciation and amortization. Management believes its use of estimates in these interim Condensed Consolidated Financial Statements to be reasonable. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management continually evaluates and revises its estimates using historical experience and other factors, including the general economic environment and actions it may take in the future. Management adjusts these estimates when facts and circumstances dictate. However, these estimates may involve significant uncertainties and judgments and cannot be determined with precision. In addition, these estimates are based on management’s best judgment at a point in time. As a result, differences between estimates and actual results could be material and would be reflected in the Company’s consolidated financial statements in future periods.</span></div>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1235801000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1318999000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
600000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
600000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1236401000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1319599000 usd
CY2023Q1 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
3100000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2937260000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-2862000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
2934398000 usd
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1098583000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
2699000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1095884000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
618183000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
477701000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1098583000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
596625000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
501958000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22700000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
66973000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
81263000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
78589000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
77980000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
76509000 usd
CY2024Q1 it Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
96387000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
477701000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472926000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1408869000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472926000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1408869000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5600000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2600000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2200000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
800000000 usd
CY2024Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1574960000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1610228000 usd
CY2024Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
29773000 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
28791000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2796016000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2640515000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
24523000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
33490000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2820539000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2674005000 usd
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1000000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78339000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79452000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
625000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
830000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78964000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80282000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.69
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.72
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.67
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.68
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5600000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50500000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45000000.0 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50500000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45000000.0 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
273885000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
407957000 usd
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2023Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
139316000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
273885000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
407957000 usd
CY2024Q1 it Interest Expenseand Other Nonoperating Income
InterestExpenseandOtherNonoperatingIncome
14328000 usd
CY2023Q1 it Interest Expenseand Other Nonoperating Income
InterestExpenseandOtherNonoperatingIncome
29757000 usd
CY2024Q1 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
0 usd
CY2023Q1 us-gaap Insured Event Gain Loss
InsuredEventGainLoss
3077000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49012000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85494000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
210545000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
295783000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2479400000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2479400000 usd
CY2024Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
22523000 usd
CY2023Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
21104000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2456877000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
2458296000 usd
CY2024Q1 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0501
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1200000000 usd
CY2023Q4 it Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
3500000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
831300000 usd
CY2024Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
489734 shares
CY2023Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
327680 shares
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
225124000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
106850000 usd
CY2024Q1 it Treasury Stock Average Price Paid Per Share
TreasuryStockAveragePricePaidPerShare
459.69
CY2023Q1 it Treasury Stock Average Price Paid Per Share
TreasuryStockAveragePricePaidPerShare
332.18
CY2024Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
-9707000 usd
CY2024Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-3652000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6055000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
1832000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-3868000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5700000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85500000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.224
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
152400000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
148400000 usd
CY2024Q1 it Unrecognized Tax Benefits Reductions Resulting From Settlements With Taxing Authorities And Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromSettlementsWithTaxingAuthoritiesAndLapseOfApplicableStatuteOfLimitations
6000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
103100000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
103100000 usd
CY2024Q1 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
32 contract
CY2024Q1 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
536470000 usd
CY2024Q1 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
9254000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-20561000 usd
CY2023Q4 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
112 contract
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
875719000 usd
CY2023Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
7239000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-24162000 usd
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-492000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-7021000 usd
CY2024Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2024Q1 it Lessee Operating Lease Optionto Terminate Term
LesseeOperatingLeaseOptiontoTerminateTerm
P1Y
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
25903000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
28799000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
5631000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
4720000 usd
CY2024Q1 us-gaap Sublease Income
SubleaseIncome
11882000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
12641000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
19652000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
20878000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
34049000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
34948000 usd
CY2024Q1 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
11110000 usd
CY2023Q1 us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
12439000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6791000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1647000 usd
CY2024Q1 it Operating Lease Cost Subleasing Activities
OperatingLeaseCostSubleasingActivities
9200000 usd
CY2023Q1 it Operating Lease Cost Subleasing Activities
OperatingLeaseCostSubleasingActivities
10600000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
98558000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
98493000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
491182000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
513406000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
589740000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
611899000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000749251-24-000024-index-headers.html Edgar Link pending
0000749251-24-000024-index.html Edgar Link pending
0000749251-24-000024.txt Edgar Link pending
0000749251-24-000024-xbrl.zip Edgar Link pending
esppplan2024amendment.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
it-03312024xex311.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
it-03312024xex312.htm Edgar Link pending
it-03312024xex32.htm Edgar Link pending
it-20240331.htm Edgar Link pending
it-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
it-20240331_def.xml Edgar Link unprocessable
it-20240331_lab.xml Edgar Link unprocessable
it-20240331_pre.xml Edgar Link unprocessable
it-20240331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
it-20240331_cal.xml Edgar Link unprocessable